We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01859156
First Posted: May 21, 2013
Last Update Posted: October 29, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Minneapolis Medical Research Foundation
  Purpose
The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.

Condition
Carbon Monoxide Exposure

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide

Resource links provided by NLM:


Further study details as provided by Minneapolis Medical Research Foundation:

Primary Outcome Measures:
  • EtCO2 [ Time Frame: Immediately upon study enrollment, an average time of 30 minutes post arrival to the hospital. ]
    The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level.


Enrollment: 151
Study Start Date: October 2006
Study Completion Date: July 2014
Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Carbon Monoxide Exposure

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients presenting to the emergency department at an urban county hospital.
Criteria

Inclusion Criteria:

  • Carbon monoxide exposure

Exclusion Criteria:

  • Less than 18 years old
  • Suicide attempt
  • Unable to provide informed consent
  • Pregnant
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01859156


Locations
United States, Minnesota
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415
Sponsors and Collaborators
Minneapolis Medical Research Foundation
Investigators
Principal Investigator: James R Miner, MD Minneapolis Medical Research Foundation
  More Information

Responsible Party: Minneapolis Medical Research Foundation
ClinicalTrials.gov Identifier: NCT01859156     History of Changes
Other Study ID Numbers: 06-2713
First Submitted: May 8, 2013
First Posted: May 21, 2013
Last Update Posted: October 29, 2014
Last Verified: October 2014

Keywords provided by Minneapolis Medical Research Foundation:
Carbon Monoxide
Carboxyhemoglobin
End-tidal carbon dioxide
Capnography

Additional relevant MeSH terms:
Carbon Monoxide Poisoning
Gas Poisoning
Poisoning
Chemically-Induced Disorders
Carbon Monoxide
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Gasotransmitters
Neurotransmitter Agents
Physiological Effects of Drugs